Exenatide improves postprandial hyperglycaemia and dyslipidaemia in metformin treated patients with type 2 diabetes

被引：0
|
作者：
Bunck, M. C. [1 ]
Corner, A. [2 ]
Diamant, M. [1 ]
Eliasson, B. [3 ]
Malloy, J. L. [4 ]
Shaginian, R. M. [5 ]
Deng, W. [4 ]
Kendall, D. M. [4 ]
Smith, U. [3 ]
Yki-Jarvinen, H. [2 ]
Heine, R. J. [1 ]
Taskinen, M. R. [2 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, Dept Endocrinol, Amsterdam, Netherlands
[2] Helsinki Univ Hosp, Dept Med, Helsinki, Finland
[3] Sahlgrens Univ Hosp, Lundberg Lab Diabet Res, Gothenburg, Sweden
[4] Amylin Pharmaceut Inc, San Diego, CA USA
[5] Eli Lilly & Co, Nederland, Houten, Netherlands
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
879
引用
收藏
页码：S351 / S351
页数：1
相关论文
共 50 条
  • [31] Quantifying the effect of exenatide and insulin glargine on postprandial glucose excursions in patients with type 2 diabetes
    Brodows, Robert G.
    Qu, Yongming
    Johns, Don
    Kim, Dennis
    Holcombe, John H.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (05) : 1395 - 1397
  • [32] Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus
    Pattanaik, S. R.
    Shah, Parag
    Baker, Abu
    Sinha, Navin
    Kumar, Neeraj
    Swami, Onkar C.
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018, 12 (04) : OE8 - OE12
  • [33] Dapagliflozin as an add-on to metformin lowers hyperglycaemia in type 2 diabetes patients inadequately controlled with metformin alone
    Bailey, C. J.
    Gross, J. L.
    Bastone, L.
    Bastien, A.
    List, J. F.
    [J]. DIABETOLOGIA, 2009, 52 : S76 - S76
  • [34] The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus
    Shaw, JTE
    Purdie, DM
    Neil, HAW
    Levy, JC
    Turner, RC
    [J]. DIABETOLOGIA, 1999, 42 (01) : 24 - 27
  • [35] Defining the Role of Insulin Lispro in the Management of Postprandial Hyperglycaemia in Patients with Type 2 Diabetes Mellitus
    D. Giugliano
    A. Ceriello
    E. Razzoli
    K. Esposito
    [J]. Clinical Drug Investigation, 2008, 28 : 199 - 210
  • [36] Safety of Exenatide Once Weekly in Patients with Type 2 Diabetes Treated with a Thiazolidinedione
    Norwood, Paul
    Pintilei, Ella
    Pop, Lavinia
    Liutkus, Joanne
    Choi, Suktae
    Giaconia, Joseph
    Trautman, Michael
    [J]. DIABETES, 2010, 59 : A195 - A195
  • [37] Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus
    Giugliano, D.
    Ceriello, A.
    Razzoli, E.
    Esposito, K.
    [J]. CLINICAL DRUG INVESTIGATION, 2008, 28 (04) : 199 - 210
  • [38] Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
    Liu, Jia
    Hu, Yanjin
    Xu, Yuan
    Jia, Yumei
    Miao, Li
    Wang, Guang
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2017, 2017
  • [39] Exenatide - A review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea)
    Cvetkovic, Risto S.
    Plosker, Greg L.
    [J]. DRUGS, 2007, 67 (06) : 935 - 954
  • [40] Exenatide: A guide to its use as an adjunct to metformin and/or a sulfonylurea in patients with type 2 diabetes mellitus
    不详
    [J]. Drugs & Therapy Perspectives, 2007, 23 (10) : 5 - 8
12345